The Endocrine Center

06/15/2026

Menopause care doesn’t have to mean endless pills, detoxes, or hormone “balancers.”

Sometimes less is more. Evidence matters the most.

06/14/2026

06/10/2026

Not all carbs are created equal — and glucose response is not just about sugar.

Protein, fiber, fat, food form, and even what you eat FIRST can change the response.

This isn’t about fear. It’s about understanding how food works so you can make choices that fit YOUR goals.

Save this for your next grocery trip 🛒

06/07/2026

“Cortisol is the reason I can’t lose weight”
→ Cortisol can influence appetite, sleep, fat distribution, and metabolism. But for most people, weight changes are multifactorial. Sleep, nutrition, medications, activity, hormones, genetics, and energy balance all matter.

“We need to check estrogen levels in menopause”
→ Menopause is usually a clinical diagnosis. Hormone levels fluctuate significantly and a single estrogen value often doesn’t explain symptoms or guide treatment the way people expect.

“You just need discipline, not a GLP-1”
→ Obesity is not simply a willpower problem. Appetite regulation involves complex brain-gut signaling, hormones, genetics, and metabolic adaptation. Lifestyle remains foundational—but for some patients, medication can be an evidence-based medical tool, not a shortcut.

“Demonizing carbs”
→ Carbohydrates are not inherently bad. Quality, quantity, fiber, protein pairing, and individual metabolic context matter far more than labeling an entire food group as the problem.

“One supplement will balance all hormones”
→ Hormones involve feedback loops across multiple organs. There is no universal supplement that “balances hormones” for everyone. Diagnosis first. Treatment second.

What hormone myth should we debunk next?

06/05/2026

POV: The audio is stuck in your head now 😂

06/04/2026

Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced form of fatty liver disease where fat accumulates in the liver and starts causing inflammation and liver cell injury. It was previously called NASH (nonalcoholic steatohepatitis).

It sits on a spectrum:
Normal liver → MASLD (fatty liver) → MASH → fibrosis → cirrhosis → possible liver failure/liver cancer

Common risk factors:
Obesity / excess visceral fat
Type 2 diabetes
Insulin resistance
Dyslipidemia (high triglycerides / low HDL)
Metabolic syndrome
Sleep apnea (association)

Symptoms:
Often none at all
Fatigue
Right upper abdominal discomfort
Mild elevation in AST/ALT
Sometimes found incidentally on imaging

How it’s evaluated:
Liver enzymes (AST, ALT)
Fibrosis scores (such as FIB-4)
Liver ultrasound
Elastography (FibroScan)
Sometimes MRI or biopsy depending on concern for fibrosis

Treatment focuses on:
Weight reduction (even modest loss helps)
Exercise (independent of weight loss)
Diabetes and lipid optimization
Limiting alcohol
In selected patients, medications may be considered depending on fibrosis stage and comorbidities.